1. CHECKPOINT INHIBITION BEFORE HAPLOIDENTICAL TRANSPLANTATION IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA PATIENTS IS ASSOCIATED WITH HIGHER PFS WITHOUT INCREASED TOXICITIES. (12th June 2019) Authors: de Philippis, C.; Legrande, F.; Bramanti, S.; Montes de Oca, C.; Dulery, R.; Bouabdallah, R.; Granada, A.; Devillier, R.; Mariotti, J.; Sarina, B.; Harbi, S.; Maisano, V.; Furst, S.; Pagliardini, T.; Weiller, P.J.; Lemarie, C.; Calmels, B.; Chabannon, C.; Carlo‐Stella, C.; Santoro, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IMPACT OF CLASS II HLA MISMATCH ON CLINICAL OUTCOMES IN HODGKIN LYMPHOMA PATIENTS RECEIVING HAPLOIDENTICAL STEM CELL TRANSPLANTATION (HAPLO‐SCT) WITH POST‐TRANSPLANT CYCLOPHOSPHAMIDE (PT‐CY). (12th June 2019) Authors: Castagna, L.; Bramanti, S.; Devillier, R.; Pagliardini, T.; Sarina, B.; Lemarie, C.; Furst, S.; Mariotti, J.; Granata, A.; de Philippis, C.; Harbi, S.; Legrand, F.; Maisano, V.; Bouabdallah, R.; Carlo‐Stella, C.; Calmels, B.; Chabannon, C.; Blaise, D.; Santoro, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P534: AZACITIDINE PLUS VENETOCLAX FOR THE TREATMENT OF RELAPSED AND FIRST-LINE AML PATIENTS. (23rd June 2022) Authors: Garciaz, S.; Hospital, M.-A.; Alary, A.-S.; Saillard, C.; Hicheri, Y.; Mohty, B.; Rey, J.; D'incan, E.; Charbonnier, A.; Ferdinand, V.; Maisano, V.; Lombardi, L.; Ittel, A.; Mozziconacci, M.-J.; Gelsi-Boyer, V.; Vey, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PB1810: OUTCOME OF ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENIC STEM CELL TRANSPLANT: A SINGLE INSTITUTION RETROSPECTIVE STUDY. (23rd June 2022) Authors: Castoldi, C.; Hicheri, Y.; Devillier, R.; Hospital, M.-A.; D'Incan, E.; Garciaz, S.; Maisano, V.; Saillard, C.; Rey, J.; Granata, A.; Harbi, S.; Legrand, F.; Furst, S.; Blaise, D.; Vey, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Vaccination strategies in lymphoproliferative disorders: Failures and successes. Issue 10 (October 2015) Authors: Allegra, A.; Russo, S.; Gerace, D.; Calabrò, L.; Maisano, V.; Innao, V.; Musolino, C. Journal: Leukemia research Issue: Volume 39:Issue 10(2015:Oct.) Page Start: 1006 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗